Beckman Coulter was formed by the merger of Beckman Instruments, founded by Dr. Beckman and Kurt Electronic Instruments, founded by the Kurt brothers. Headquartered in Brea, California, USA, as one of the global leaders in in vitro diagnosis, Beckman Coulter shoulders the mission of "incessant medical exploration and wholehearted diagnosis", and perseveres in exploring breakthroughs and innovations in testing technology, and devotes itself to all over the world. Medical institutions and laboratories provide innovative and intelligent diagnostic solutions.

As one of the first international in vitro diagnostic companies to enter the Chinese market, Beckman Coulter began setting up representative offices and repair stations in many places in China 40 years ago. Since the Suzhou Reagent Factory was completed in 1997, Beckman Coulter started the chapter of localized production. In 2011, he officially joined the Danaher Group. Under the guidance of the Danaher's "Creating China" strategy, he continued to increase investment in local production, local R&D and innovation and local cooperation to meet the diversity needs of Chinese customers. In 2023, the China R&D and manufacturing base of the Danaher Diagnostic Platform will be officially put into use. As an important operating company, Beckman Coulter's local production and R&D capabilities will be comprehensively improved. At present, China's "intelligent" manufacturing of all major equipment has been achieved, and in the future, the comprehensive domestic production of all products will be accelerated.

Beckman Coulter Diagnostics is proud to be a member of Danaher.

Danaher's leading position in technology has put Beckman Coulter Diagnostics' solutions at the forefront of the industry and benefit more people. Being a member of Danaher means providing customers with extensive and in-depth expertise and solutions.